NextPlat Q1 revenue falls on lower reimbursement rates
NextPlat Corp NXPL | 0.00 |
Overview
US healthcare and tech solutions provider's Q1 revenue fell 29% yr/yr, driven by lower reimbursement rates
Gross margin for Q1 rose to a record 35%, boosted by new contracted medication fulfillment services
Company cut operating expenses 9% sequentially, narrowing net loss by 42% yr/yr
Outlook
Company expects positive operating income in the latter half of 2026
Healthcare segment gross margin anticipated to remain elevated through 2026
Company plans to launch new healthcare e-commerce site before end of Q2 2026
Result Drivers
LOWER REIMBURSEMENT RATES - Co said healthcare revenue fell due to lower reimbursement rates and a contraction in prescription volume
CONTRACTED SERVICES & DRUG COSTS - Gross margin rose due to new contracted medication fulfillment services and improved drug costing from the Medicare Maximum Fair Price program
EXPENSE REDUCTIONS - Operating expenses declined due to reductions in headcount, executive compensation, and professional fees
Company press release: ID:nPnBV92ha
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q1 Revenue |
|
$9.90 mln |
|
Q1 EPS |
|
-$0.42 |
|
Q1 Gross Margin |
|
35.00% |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
